カテゴリー： QYResearch, 世界, 医療/バイオ

ペット用抗炎症薬のグローバル市場2023年：粉末状、液体状

◆英語タイトル：Global Anti-inflammatory Medicine for Pets Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8674）◆商品コード：QYR23MA8674
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：92
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のペット用抗炎症薬市場について調査・分析し、世界のペット用抗炎症薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（粉末状、液体状）、用途別セグメント分析（猫、犬、爬虫類、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Zoetis、Boehringer Ingelheim、Merck、Elanco、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Ouro Fino Saude、Norbrook、Jindun、Wuhan chopperlvya、CAHICなどが含まれています。世界のペット用抗炎症薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ペット用抗炎症薬市場規模を推定する際に考慮しました。

・ペット用抗炎症薬市場の概要
- 製品の定義
- ペット用抗炎症薬のタイプ別セグメント
- 世界のペット用抗炎症薬市場規模：タイプ別分析（粉末状、液体状）
- ペット用抗炎症薬の用途別セグメント
- 世界のペット用抗炎症薬市場規模：用途別分析（猫、犬、爬虫類、その他）
- 世界のペット用抗炎症薬市場規模予測（2018年-2029年）
- ペット用抗炎症薬の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ペット用抗炎症薬市場の競争状況およびトレンド

・ペット用抗炎症薬の地域別市場規模
- 北米のペット用抗炎症薬市場規模（2018年-2029年）
- アメリカのペット用抗炎症薬市場規模（2018年-2029年）
- ヨーロッパのペット用抗炎症薬市場規模（2018年-2029年）
- アジア太平洋のペット用抗炎症薬市場規模（2018年-2029年）
- 中国のペット用抗炎症薬市場規模（2018年-2029年）
- 日本のペット用抗炎症薬市場規模（2018年-2029年）
- 韓国のペット用抗炎症薬市場規模（2018年-2029年）
- インドのペット用抗炎症薬市場規模（2018年-2029年）
- オーストラリアのペット用抗炎症薬市場規模（2018年-2029年）
- 中南米のペット用抗炎症薬市場規模（2018年-2029年）
- 中東・アフリカのペット用抗炎症薬市場規模（2018年-2029年）

・タイプ別セグメント：粉末状、液体状
- 世界のペット用抗炎症薬のタイプ別販売量（2018年-2023年）
- 世界のペット用抗炎症薬のタイプ別売上（2018年-2023年）
- 世界のペット用抗炎症薬のタイプ別価格

・用途別セグメント：猫、犬、爬虫類、その他
- 世界のペット用抗炎症薬の用途別販売量（2018年-2023年）
- 世界のペット用抗炎症薬の用途別売上（2018年-2023年）
- 世界のペット用抗炎症薬の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Zoetis、Boehringer Ingelheim、Merck、Elanco、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Ouro Fino Saude、Norbrook、Jindun、Wuhan chopperlvya、CAHIC

・産業チェーンと販売チャネルの分析
- ペット用抗炎症薬産業チェーン分析
- ペット用抗炎症薬の主要原材料
- ペット用抗炎症薬の販売チャネル
- ペット用抗炎症薬のディストリビューター
- ペット用抗炎症薬の主要顧客

・ペット用抗炎症薬市場ダイナミクス
- ペット用抗炎症薬の業界動向
- ペット用抗炎症薬市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
Highlights
The global Anti-inflammatory Medicine for Pets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Anti-inflammatory Medicine for Pets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Anti-inflammatory Medicine for Pets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Anti-inflammatory Medicine for Pets include Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Ouro Fino Saude, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Medicine for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Medicine for Pets.
The Anti-inflammatory Medicine for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-inflammatory Medicine for Pets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Medicine for Pets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan chopperlvya
CAHIC
Segment by Type
Powder
Liquid
Segment by Application
Cat
Dog
Reptile
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-inflammatory Medicine for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-inflammatory Medicine for Pets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Anti-inflammatory Medicine for Pets Market Overview
1.1 Product Overview and Scope of Anti-inflammatory Medicine for Pets
1.2 Anti-inflammatory Medicine for Pets Segment by Type
1.2.1 Global Anti-inflammatory Medicine for Pets Market Value Comparison by Type (2023-2029)
1.2.2 Powder
1.2.3 Liquid
1.3 Anti-inflammatory Medicine for Pets Segment by Application
1.3.1 Global Anti-inflammatory Medicine for Pets Market Value by Application: (2023-2029)
1.3.2 Cat
1.3.3 Dog
1.3.4 Reptile
1.3.5 Other
1.4 Global Anti-inflammatory Medicine for Pets Market Size Estimates and Forecasts
1.4.1 Global Anti-inflammatory Medicine for Pets Revenue 2018-2029
1.4.2 Global Anti-inflammatory Medicine for Pets Sales 2018-2029
1.4.3 Global Anti-inflammatory Medicine for Pets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-inflammatory Medicine for Pets Market Competition by Manufacturers
2.1 Global Anti-inflammatory Medicine for Pets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-inflammatory Medicine for Pets Average Price by Manufacturers (2018-2023)
2.4 Global Anti-inflammatory Medicine for Pets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Product Type & Application
2.7 Anti-inflammatory Medicine for Pets Market Competitive Situation and Trends
2.7.1 Anti-inflammatory Medicine for Pets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-inflammatory Medicine for Pets Players Market Share by Revenue
2.7.3 Global Anti-inflammatory Medicine for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-inflammatory Medicine for Pets Retrospective Market Scenario by Region
3.1 Global Anti-inflammatory Medicine for Pets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-inflammatory Medicine for Pets Global Anti-inflammatory Medicine for Pets Sales by Region: 2018-2029
3.2.1 Global Anti-inflammatory Medicine for Pets Sales by Region: 2018-2023
3.2.2 Global Anti-inflammatory Medicine for Pets Sales by Region: 2024-2029
3.3 Global Anti-inflammatory Medicine for Pets Global Anti-inflammatory Medicine for Pets Revenue by Region: 2018-2029
3.3.1 Global Anti-inflammatory Medicine for Pets Revenue by Region: 2018-2023
3.3.2 Global Anti-inflammatory Medicine for Pets Revenue by Region: 2024-2029
3.4 North America Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.4.1 North America Anti-inflammatory Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-inflammatory Medicine for Pets Sales by Country (2018-2029)
3.4.3 North America Anti-inflammatory Medicine for Pets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.5.1 Europe Anti-inflammatory Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-inflammatory Medicine for Pets Sales by Country (2018-2029)
3.5.3 Europe Anti-inflammatory Medicine for Pets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-inflammatory Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-inflammatory Medicine for Pets Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-inflammatory Medicine for Pets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.7.1 Latin America Anti-inflammatory Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-inflammatory Medicine for Pets Sales by Country (2018-2029)
3.7.3 Latin America Anti-inflammatory Medicine for Pets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-inflammatory Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-inflammatory Medicine for Pets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-inflammatory Medicine for Pets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-inflammatory Medicine for Pets Sales by Type (2018-2029)
4.1.1 Global Anti-inflammatory Medicine for Pets Sales by Type (2018-2023)
4.1.2 Global Anti-inflammatory Medicine for Pets Sales by Type (2024-2029)
4.1.3 Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2018-2029)
4.2 Global Anti-inflammatory Medicine for Pets Revenue by Type (2018-2029)
4.2.1 Global Anti-inflammatory Medicine for Pets Revenue by Type (2018-2023)
4.2.2 Global Anti-inflammatory Medicine for Pets Revenue by Type (2024-2029)
4.2.3 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2018-2029)
4.3 Global Anti-inflammatory Medicine for Pets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti-inflammatory Medicine for Pets Sales by Application (2018-2029)
5.1.1 Global Anti-inflammatory Medicine for Pets Sales by Application (2018-2023)
5.1.2 Global Anti-inflammatory Medicine for Pets Sales by Application (2024-2029)
5.1.3 Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2018-2029)
5.2 Global Anti-inflammatory Medicine for Pets Revenue by Application (2018-2029)
5.2.1 Global Anti-inflammatory Medicine for Pets Revenue by Application (2018-2023)
5.2.2 Global Anti-inflammatory Medicine for Pets Revenue by Application (2024-2029)
5.2.3 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2018-2029)
5.3 Global Anti-inflammatory Medicine for Pets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Zoetis Anti-inflammatory Medicine for Pets Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck Anti-inflammatory Medicine for Pets Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Elanco Anti-inflammatory Medicine for Pets Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Virbac Anti-inflammatory Medicine for Pets Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Dechra Veterinary Products
6.6.1 Dechra Veterinary Products Corporation Information
6.6.2 Dechra Veterinary Products Description and Business Overview
6.6.3 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product Portfolio
6.6.5 Dechra Veterinary Products Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ceva Anti-inflammatory Medicine for Pets Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Vetoquinol Anti-inflammatory Medicine for Pets Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Ouro Fino Saude
6.9.1 Ouro Fino Saude Corporation Information
6.9.2 Ouro Fino Saude Description and Business Overview
6.9.3 Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ouro Fino Saude Anti-inflammatory Medicine for Pets Product Portfolio
6.9.5 Ouro Fino Saude Recent Developments/Updates
6.10 Norbrook
6.10.1 Norbrook Corporation Information
6.10.2 Norbrook Description and Business Overview
6.10.3 Norbrook Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Norbrook Anti-inflammatory Medicine for Pets Product Portfolio
6.10.5 Norbrook Recent Developments/Updates
6.11 Jindun
6.11.1 Jindun Corporation Information
6.11.2 Jindun Anti-inflammatory Medicine for Pets Description and Business Overview
6.11.3 Jindun Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jindun Anti-inflammatory Medicine for Pets Product Portfolio
6.11.5 Jindun Recent Developments/Updates
6.12 Wuhan chopperlvya
6.12.1 Wuhan chopperlvya Corporation Information
6.12.2 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Description and Business Overview
6.12.3 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product Portfolio
6.12.5 Wuhan chopperlvya Recent Developments/Updates
6.13 CAHIC
6.13.1 CAHIC Corporation Information
6.13.2 CAHIC Anti-inflammatory Medicine for Pets Description and Business Overview
6.13.3 CAHIC Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 CAHIC Anti-inflammatory Medicine for Pets Product Portfolio
6.13.5 CAHIC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-inflammatory Medicine for Pets Industry Chain Analysis
7.2 Anti-inflammatory Medicine for Pets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-inflammatory Medicine for Pets Production Mode & Process
7.4 Anti-inflammatory Medicine for Pets Sales and Marketing
7.4.1 Anti-inflammatory Medicine for Pets Sales Channels
7.4.2 Anti-inflammatory Medicine for Pets Distributors
7.5 Anti-inflammatory Medicine for Pets Customers
8 Anti-inflammatory Medicine for Pets Market Dynamics
8.1 Anti-inflammatory Medicine for Pets Industry Trends
8.2 Anti-inflammatory Medicine for Pets Market Drivers
8.3 Anti-inflammatory Medicine for Pets Market Challenges
8.4 Anti-inflammatory Medicine for Pets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ペット用抗炎症薬のグローバル市場2023年：粉末状、液体状(Global Anti-inflammatory Medicine for Pets Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ペット用駆虫薬の世界市場見通し2023年-2029年
  • ペット用体外駆虫薬の世界市場見通し2023年-2029年
  • 非ステロイド性抗炎症薬（NSAID）の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆